|
Total revenue
|
|
$2.2m
|
$0
|
$19.1m
|
$77.1m
|
$186.4m
|
$336.9m
|
$521.3m
|
|
Cost of sales
|
|
$473k
|
$0
|
$1.9m
|
$12.4m
|
$47.0m
|
$81.6m
|
$100.2m
|
|
Research and development
|
|
$43.0m
|
$81.6m
|
$131.4m
|
$106.8m
|
$102.6m
|
$140.6m
|
$186.2m
|
|
Selling, general and administrative
|
|
—
|
—
|
$59.2m
|
$89.1m
|
$145.9m
|
$202.2m
|
$257.0m
|
|
Total operating expenses
|
|
$54.7m
|
$104.3m
|
$192.6m
|
$208.3m
|
$295.5m
|
$424.5m
|
$543.4m
|
|
Loss from operations
|
|
($54.7m)
|
($104.3m)
|
($173.4m)
|
($131.2m)
|
($109.2m)
|
($87.6m)
|
($22.1m)
|
|
Interest income
|
|
$2.2m
|
$1.6m
|
$366k
|
$3.9m
|
$13.7m
|
$13.8m
|
$12.7m
|
|
Loss from termination of revenue interest purchase agreement
|
|
—
|
—
|
$0
|
$0
|
($49.1m)
|
$0
|
$0
|
|
Loss before provision for income taxes
|
|
($52.5m)
|
($103.3m)
|
($84.0m)
|
($142.1m)
|
($162.4m)
|
($86.9m)
|
($21.4m)
|
|
Provision for income taxes
|
|
$21k
|
$6k
|
$37k
|
($6.4m)
|
$991k
|
$1.0m
|
$1.9m
|
|
Net loss
|
|
($52.6m)
|
($103.3m)
|
($84.0m)
|
($135.7m)
|
($163.4m)
|
($87.9m)
|
($23.4m)
|
|
Net loss per share, basic (in dollars per share)
|
|
—
|
—
|
($3)
|
($4)
|
($4)
|
($2)
|
($0)
|
|
Net loss per share, diluted (in dollars per share)
|
|
($5)
|
($4)
|
($3)
|
($4)
|
($4)
|
($2)
|
($0)
|
|
Weighted-average shares of common stock outstanding, basic (in shares)
|
|
—
|
—
|
30.3m
|
33.8m
|
40.9m
|
47.5m
|
50.2m
|
|
Weighted-average shares of common stock outstanding, diluted (in shares)
|
|
—
|
—
|
30.3m
|
34.0m
|
40.9m
|
47.5m
|
50.2m
|
|
Interest expense
|
|
$0
|
($335k)
|
($17.6m)
|
($16.0m)
|
($15.1m)
|
($14.3m)
|
($14.4m)
|
|
Other income (expense), net
|
|
($21k)
|
($192k)
|
($582k)
|
$365k
|
($2.8m)
|
$1.2m
|
$2.4m
|